Heredodegenerative Disorders, Nervous System: Clinical Trials

2 trials for Heredodegenerative Disorders, Nervous System, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 suspended. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Suspended 2
Phase 21Suspended 1

Follow Heredodegenerative Disorders, Nervous System: new trials by email Literature Review of Heredodegenerative Disorders, Nervous System trials Research Report on Heredodegenerative Disorders, Nervous System

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Emavusertib, Venetoclax - Acute Myelogenous Leukemia, Myelodysplastic Syndrome
Phase 1 / Phase 2SuspendedCuris, Inc.3662020-07-062026-03-19
A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer
EZN-4176 - Prostatic Neoplasm
Phase 1SuspendedEnzon Pharmaceuticals, Inc.1502011-03-012012-12-18

Narrower conditions

Adenocarcinoma (1)  ·  Bulbo-Spinal Atrophy, X-Linked (1)  ·  Hereditary Sensory and Autonomic Neuropathies (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasm Metastasis (1)  ·  Prostatic Neoplasms (1)  ·  Recurrence (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Nervous System Diseases (2)  ·  Neurodegenerative Diseases (2)  ·  Neuromuscular Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Bone Marrow Diseases (1)  ·  Carcinoma (1)  ·  Central Nervous System Diseases (1)  ·  Congenital Abnormalities (1)  ·  Disease Attributes (1)

Interventions

5'-ACCaagtttcttcAGC-3' (1)  ·  CA-4948 (1)  ·  venetoclax (1)

Sponsors

Curis, Inc. (1)  ·  Enzon Pharmaceuticals, Inc. (1)

Countries

United States (2)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Poland (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Aby Buchbinder, MD (1)  ·  Daniel Danila, MD (1)  ·  Johann de Bono, MD (1)